Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer.
暂无分享,去创建一个
J. Reynolds | D. Hollywood | E. Mulligan | P. Keeling | S. Rowley | P. Byrne | M. Macguill | J. Kennedy | N. Ravi | Patrick J. Byrne | John V. Reynolds
[1] Fábio Guilherme Campos,et al. Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.
[2] A. Venturi,et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis , 2004, Gut.
[3] J. Reynolds,et al. NF-&kgr;B Activation in Esophageal Adenocarcinoma: Relationship to Barrett's Metaplasia, Survival, and Response to Neoadjuvant Chemoradiotherapy , 2004, Annals of surgery.
[4] S. Larson,et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] C. Reed,et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S. , 2002, Cancer.
[6] J. Urschel,et al. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. , 2002, American journal of surgery.
[7] Scott W. Lowe,et al. Apoptosis A Link between Cancer Genetics and Chemotherapy , 2002, Cell.
[8] J. Reynolds,et al. Spontaneous and inducible apoptosis in oesophageal adenocarcinoma , 2001, British Journal of Cancer.
[9] J. Reynolds,et al. A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy. , 2001, Journal of clinical pathology.
[10] M. Schwaiger,et al. Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography , 2001, Annals of surgery.
[11] R. Glynne-Jones,et al. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer , 2001, The British journal of surgery.
[12] D. Kelsen. Preoperative chemoradiotherapy for esophageal cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Martino,et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. , 2000, The New England journal of medicine.
[14] H. Bartelink,et al. Radiation-induced apoptosis , 2000, Cell and Tissue Research.
[15] J. Bosset,et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. , 1997, The New England journal of medicine.
[16] D. Wickerham,et al. Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] T. Walsh,et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.
[18] J. Petiot,et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.
[19] J. Hickman,et al. Apoptosis induced by anticancer drugs , 1992, Cancer and Metastasis Reviews.
[20] S. Shackney,et al. Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review. , 1978, Annals of internal medicine.
[21] J. Reynolds,et al. Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[22] T. Jacks,et al. The role of p53 in tumour suppression: lessons from mouse models , 1999, Cellular and Molecular Life Sciences CMLS.
[23] S. Lowe,et al. Clinical implications of p53 mutations , 1999, Cellular and Molecular Life Sciences CMLS.
[24] J. Bosset,et al. Chemotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus , 1998 .
[25] E. Petricoin,et al. Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.